ONN^® - OncLive News Network^®

OncLive® will be premiering OncLive® News Network: On Location at the 2024 San Antonio Breast Cancer Symposium! Each day, we will broadcast a series of interviews with top thought leaders, to learn their thoughts and reactions to data presented across oncology during the conference.

OncLive® will be premiering OncLive® News Network: On Location at the 2024 ASH Annual Meeting! Each day, we will broadcast a series of interviews with top thought leaders, to learn their thoughts and reactions to data presented across oncology during the conference.

Jessica Donington, MD, MSCR, Melina Elpi Marmarelis, MD, and Ibiayi Dagogo-Jack, MD, discuss biomarker testing in non–small cell lung cancer.

Mohammed Najeeb Al Hallak, MD, MS, and Sakti Chakrabarti, MD, discuss updates in HCC and GI cancers from the 2024 ESMO Congress.

Gregory J. Riely, MD, PhD, and Benjamin Besse, MD, discuss updates in ALK-positive and ROS1-positive non–small cell lung cancer.

James K. McCloskey, MD, and Harry P. Erba, MD, PhD, discuss updates in acute myeloid leukemia following the 2024 SOHO Annual Meeting.

Yoshiaki Nakamura, MD, PhD, discusses how a methylation-based circulating tumor DNA assay can enhance minimal residual disease detection and improve prognosis in patients with previously treated stage II-III colorectal cancer.

Samuel Cytryn, MD, and David B. Zhen, MD, on updates in gastrointestinal cancers from the 2024 ASCO Annual Meeting and Gastrointestinal Cancers Symposium.

Marc S. Hoffmann, MD, and Mazyar Shadman, MD, MPH, discuss the real-world use of BTK inhibitors for patients with chronic lymphocytic leukemia.

Joyce A. O’Shaughnessy, MD, and Neil M. Iyengar, MD, discuss the changing treatment landscape of patients with advanced or metastatic HER2-positive breast cancer.

Ibrahim T. Aldoss, MD; and Elias Jabbour, MD, discuss updates to the treatment paradigm of Philadelphia chromosome–positive acute lymphoblastic leukemia.

OncLive® will be LIVE with OncLive® News Network: On Location at the 2024 ASCO Annual Meeting. Each day, we will broadcast a series of interviews with top thought leaders, to learn their thoughts and reactions to data presented across oncology during the conference.

Milind Javle, MD; Rachna Shroff, MD, MS, FASCO; and a patient discuss advances in treatment options in advanced biliary tract cancer.

OncLive co-hosts Kristie L. Kahl and Andrew Svonavec highlight abstracts to look out for at the upcoming ASCO Annual Meeting in Chicago, with some additional tidbits to round out the main event.

Zofia Piotrowska, MD, MHS, and Martin Dietrich, MD, PhD, explore the advantages of biomarker testing and next-generation sequencing in diagnosing and managing non-small cell lung cancer.

D. Ross Camidge, MD, PhD,of University of Colorado Health Lung Cancer Clinic – Anschutz Medical Campus, discusses research efforts for patients with non–small cell lung cancer who harbor NRG1 fusions.